The metabolic and renal effects of adrenaline and milrinone in patients with myocardial dysfunction after coronary artery bypass grafting

Critical Care

Volumn 11, Issue , 2007, Pages

  Heringlake, Matthias ^a   Wernerus, Marit ^a   Grünefeld, Julia ^a   Klaus, Stephan ^b   Heinze, Hermann ^a   Bechtel, Matthias ^a   Bahlmann, Ludger ^c   Poeling, Jochen ^d   Schön, Julika ^a  

^a UNIVERSITY OF LÜBECK   (Germany)

^b Herz Jesu Krankenhaus Munster Hiltrup   (Germany)

^c Krankenhaus Weser Egge   (Germany)

^d Schuchtermann Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADRENALIN; ALPHA 1 MICROGLOBULIN; CYSTATIN C; GLUCOSE; INSULIN; LACTIC ACID; MILRINONE; NITROPRUSSIDE SODIUM; NORADRENALIN; PYRUVIC ACID; ALPHA GLOBULIN; ALPHA-1-MICROGLOBULIN; BICARBONATE; CYSTATIN; PHOSPHODIESTERASE INHIBITOR; UNCLASSIFIED DRUG;

ACID BASE BALANCE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CREATININE CLEARANCE; DRUG EFFICACY; DRUG MEGADOSE; GLUCOSE BLOOD LEVEL; HEART HEMODYNAMICS; HEART INDEX; HEART OUTPUT; HUMAN; HYPERGLYCEMIA; HYPERLACTATEMIA; INTENSIVE CARE UNIT; KIDNEY FAILURE; KIDNEY FUNCTION; LACTATE BLOOD LEVEL; MYOCARDIAL DISEASE; PILOT STUDY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROTEINURIA; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; URINARY EXCRETION; BLOOD; CARDIOMYOPATHY; COMPARATIVE STUDY; FEMALE; FORWARD HEART FAILURE; KIDNEY FUNCTION TEST; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; POSTOPERATIVE CARE; PROSPECTIVE STUDY; URINE;

AGED; ALPHA-GLOBULINS; BICARBONATES; BLOOD GLUCOSE; CARDIAC OUTPUT, LOW; CARDIOMYOPATHIES; CORONARY ARTERY BYPASS; CYSTATINS; EPINEPHRINE; FEMALE; HUMANS; KIDNEY FUNCTION TESTS; MALE; MIDDLE AGED; MILRINONE; PHOSPHODIESTERASE INHIBITORS; PILOT PROJECTS; POSTOPERATIVE CARE; PROSPECTIVE STUDIES;

EID: 39549095616     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc5904     Document Type: Article

References (32)

1. Elwatidy AMF Fafalah MA Bukhari EA Aljubair KA Syed A Ashmeg AK Alfagih MR Antegrade cristalloid cardioplegia vs. antegrade/retrograde cold and tepid blood cardioplegia Ann Thorac Surg 1999 68 447-453 10.1016/ S0003-4975(99)00359-8 10475411
2. Gillies M Bellomo R Doolan L Buxton B Bench-to-bedside review: Inotropic drug therapy after adult cardiac surgery - a systematic literature review Critical Care 2005 9 266-279 1175868 15987381 10.1186/cc3024
3. Leone M Vallet B Teboul JL Mateo J Bastien O Martin C Survey of the use of catecholamines by French physicians Intensive Care Med 2004 30 984-988 10.1007/s00134-004-2172-1 14997293
4. Kastrup M Markewitz A Spies C Carl M Erb J Grosse J Schirmer U Current practice of hemodynamic monitoring and vasopressor and inotropic therapy in post-operative cardiac surgery patients in Germany: Results from a postal survey Acta Anaesthesiol Scand 2007 51 347-358 10.1111/ j.1399-6576.2006.01190.x 17096667
5. Sakr Y Reinhart K Vincent JL Sprung CL Moreno R Ranieri VM De Backer D Payen D Does dopamine administration in shock influence outcome? Results of the Sepsis Occurrence in Acutely Ill Patients (SOAP Study) Crit Care Med 2006 34 589-597 10.1097/01.CCM.0000201896.45809.E3 16505643
6. Levy B Lactate and shock: The metabolic view Curr Opin Crit Care 2006 12 315-321 10.1097/01.ccx.0000235208.77450.15 16810041
7. Meier-Hellmann A Reinhart K Bredle DL Specht M Spies CD Hannemann L Epinephrine impairs splanchnic perfusion in septic shock Crit Care Med 1997 25 399-404 10.1097/00003246-199703000-00005 9118653
8. Heringlake M Knappe M Vargas Hein O Lufft H Kindgen-Milles D Boettiger BW Weigand MR Klaus S Schirmer U Renal dysfunction according to the ADQI-RIFLE system and clinical practice patterns after cardiac surgery in Germany Minerva Anestesiol 2006 72 645-654 16865083
9. Boldt J Brosch C Lehmann A Suttner S Isgro M The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III - inhibitor enoximone Anesth Analg 2004 99 1009-1017 10.1213/ 01.ANE.0000132969.88550.96 15385341
10. Boldt J Brosch C Suttner S Piper SN Lehmann A Werling C Prophylactic use of the phospodiesterase III inhibitor enoximone in elderly cardiac surgery patients: Effect on hemodynamics, inflammation, and markers of organ function Intensive Care Med 2002 28 1462-1469 10.1007/ s00134-002-1435-y 12373472
11. Amin K Bastani B Incidence of acute renal failure associated with milrinone J Pharm Technol 2005 21 21-24
12. Bahlmann L Misfeld M Klaus S Leptien A Heringlake M Schmucker P Sievers HH Ungerstedt U Kraatz EG Myocardial redox state during coronary artery bypass grafting assessed with microdialysis Intensive Care Med 2004 30 889-894 10.1007/s00134-004-2199-3 14985951
13. Maillet JM Le Besnerais P Cantoni M Nataf P Ruffenach A Lessana A Brodaty D Frequency, risk factors, and outcome of hyperlactatemia after cardiac surgery Chest 2003 123 1361-1366 10.1378/chest.123.5.1361 12740248
14. Ensinger H Geisser W Brinkmann A Wachter U Vogt J Radermacher P Georgieff M Traeger K Metabolic effects of norepinephrine and dobutamine in healthy volunteers Shock 2002 18 495-500 10.1097/ 00024382-200212000-00002 12462555
15. Levy B Bollaert PE Charpentier C Nace L Audibert G Bauer P Nabet P Larcan A Comparison of norepinephrine and dobutamine to epinephrine for hemodynamics, lactate metabolism, and gastric tonometric variables in septic shock: A prospective, randomized study Intensive Care Med 1997 23 282-287 10.1007/s001340050329 9083230
16. Totaro RJ Raper RF Epinephrine-induced lactic acidosis following cardiopulmonary bypass Crit Care Med 1997 25 1693-1699 10.1097/ 00003246-199710000-00019 9377884
17. Raper RF Cameron G Walker D Bowey CJ Type B lactic acidosis following cardiopulmonary bypass Crit Care Med 1997 25 46-51 10.1097/ 00003246-199701000-00011 8989175
18. Boldt J Piper S Murray P Lehmann A Severe lactic acidosis after cardiac surgery: Sign of perfusion deficits J Cardiothorac Vasc Anesth 1999 13 220-224 10.1016/S1053-0770(99)90093-9 10230962
19. Levy B Gibot S Franck P Cravoisy A Bollaert PE Relation between muscle NaKATPase activity and raised lactate concentrations in septic shock: A prospective study Lancet 2005 365 871-875 10.1016/S0140-6736(05)71045-X 15752531
20. Fiaccadori E Vezzani A Coffrini E Guariglia A Ronda N Tortorella G Vitali P Pincolini S Beghi C Fesani F Cell metabolism in patients undergoing major valvular heart surgery: Relationship with intra and postoperative hemodynamics, oxygen transport, and oxygen utilization patterns Crit Care Med 1989 17 1286-1292 2591223
21. Levy B Mansart A Montemont C Gibot S Mallie JP Regnault V Lecompte T Lacolley P Myocardial lactate deprivation is associated with decreased cardiovascular performance, decreased myocardial energetics, and early death in endotoxic shock Intensive Care Med 2007 33 495-502 10.1007/ s00134-006-0523-9 17242933
22. Van den Berghe G Wouters P Weekers F Verwaest C Bruyninckx F Schetz M Vlasselaers D Ferdinande P Lauwers P Bouillon R Intensive insulin therapy in the critically ill patients N Engl J Med 2001 345 1359-1367 10.1056/NEJMoa011300 11794168
23. Ouattara A Lecomte P Le Manach Y Landi M Jacqueminet S Platonov I Bonnet N Riou B Coriat P Poor intraoperative blood glucose control is associated with a worsened hospital outcome after cardiac surgery in diabetic patients Anesthesiology 2005 103 687-694 10.1097/ 00000542-200510000-00006 16192760
24. Weil MH Afifi AA Experimental and clinical studies on lactate and pyruvate as indicators of the severity of acute circulatory failure (shock) Circulation 1970 41 989-1001 5482913
25. Chertow GM Levy EM Hammermeister KE Griver F Daley J Independent association between acute renal failure and mortality following cardiac surgery Am J Med 1998 104 343-348 10.1016/S0002-9343(98)00058-8 9576407
26. Lassnigg A Schmidlin D Mouhieddine M Bachmann LM Druml W Bauer P Hiesmayer M Minimal changes of serum creatinine predict prognosis in patients after cardiothoracic surgery: A prospective cohort study J Am Soc Nephrol 2004 15 1597-1605 10.1097/01.ASN.0000130340.93930.DD 15153571
27. Garwood S Renal insufficiency after cardiac surgery Semin Cardiothorac Vasc Anesth 2004 8 227-241 10.1177/108925320400800305 15375482
28. Gormley SMC McBride WT Armstrong MA Young IS McClean E MacGowan SW Campalani G McMurray TJ Plasma and urinary cytokine homeostasis and renal dysfunction during cardiac surgery Anesthesiology 2000 93 1210-1216 10.1097/00000542-200011000-00013 11046208
29. Gormley SMC McBride WT Armstrong MA McClean E MacGowan SW Campalani G McMurray TJ Plasma and urinary cytokine homeostasis and renal function during cardiac surgery without cardiopulmonary bypass Cytokine 2002 17 61-65 10.1006/cyto.2001.0972 11886172
30. Villa P Jimenez M Soriano MC Manzanares J Casanovas P Serum cystatin C concentration as a marker of acute renal dysfunction in critically ill patients Crit Care 2005 9 R139-R143 1175926 15774046 10.1186/cc3044
31. Zhu J Yin R Wu H Yi J Luo J Dong G Jing H Cystatin C as a reliable marker of renal function following heart valve replacement surgery with cardiopulmonary bypass Clin Chim Acta 2006 374 116-121 10.1016/ j.cca.2006.06.001 16876777
32. Abu-Omar Y Mussa S Naik MJ MacCarthy N Standing S Taggart DP Evaluation of Cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery Eur J Cardiothorac Surg 2005 27 893-898 10.1016/ j.ejcts.2004.12.063 15848332